Related Experiment Videos

Single high-dose rectal acetaminophen in children

Marie L Varela1, Mary Ann Howland

  • 1Stony Brook University Hospital, Stony Brook, NY, USA. mvarel@notes.cc.sunysb.edu

The Annals of Pharmacotherapy
|October 14, 2004
PubMed

Insights

High-dose rectal acetaminophen for pediatric postoperative pain is not recommended due to insufficient evidence and study variability. More research is needed to establish safe and effective dosing protocols for pain management in children.

Area of Science:

  • Pediatric pharmacology
  • Pain management
  • Clinical evidence synthesis

Background:

  • Rectal acetaminophen is used for pediatric pain relief.
  • High-dose ( >30 mg/kg) regimens have been explored for postoperative pain control.

Purpose of the Study:

  • To evaluate the evidence supporting one-time, high-dose rectal acetaminophen for pediatric postoperative pain.
  • To determine if current data justifies this pain management strategy.

Main Methods:

  • Comprehensive literature search of MEDLINE and bibliographic databases (1966-May 2004).
  • Inclusion of all identified studies on acetaminophen doses >30 mg/kg in children.
  • Review of ten randomized controlled trials and pharmacokinetic studies.

Main Results:

  • Ten relevant studies were identified and reviewed.
  • Significant heterogeneity observed across studies in design, objectives, populations, dosing, formulation, and monitoring.
  • Rectal acetaminophen use for postoperative pain in children showed variable outcomes.

Conclusions:

  • Limited and highly variable study data preclude a recommendation for one-time, high-dose rectal acetaminophen.
  • Lack of standardization in study parameters hinders evidence-based practice.
  • Additional doses are often required, questioning the efficacy of a single high dose.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...